## Abstract Mixed cultures of leukemic cells from acute lymphatic leukemia patients with autologous remission lymphocytes and of leukemic cells from both acute lymphatic leukemia patients and chronic lymphocytic leukemia patients with the lymphocytes from an HL‐A identical sibling were performed to
Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins
✍ Scribed by Eugene B. Rosenberg; Ronald B. Herberman; Paul H. Levine; Roger H. Halterman; James L. McCov; John R. Wunderlich
- Publisher
- John Wiley and Sons
- Year
- 1972
- Tongue
- French
- Weight
- 700 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cellular cytotoxicity reactions to human leukemia cells were measured with a sensitive, quantitative assay of cell‐mediated immunity. Freshly explanted leukemia cells, rather than tissue culture cells, were tested to ensure that the antigens detected were not acquired in vitro. Identical twins, one member of each pair having leukemia, were used to minimize genetic variables and histocompatibility differences, thereby providing comparable normal cells to control for the leukemic cells.
Leukemia‐associated antigens were detected on the cells of seven of ten leukemic patients. In no instance was reactivity observed against only the cells of the normal twin. Lymphocytes from three identical twins, seven parents, two siblings and eight normal unrelated individuals were cytotoxic for cells from the leukemic patients but not for cells from these patients' normal identical twins. Lymphocytes from adults had a much higher incidence of reactivity (46%) against the leukemic cells than did the cells of children (9%). Positive lymphocyte cytotoxicity reactions to leukemia‐associated antigens indicate previous sensitization which could have resulted from infection with an environmental agent such as a virus.
📜 SIMILAR VOLUMES
## Freiburg, Fed. Rep. G e m n y . Antibody titers to Epstein-Barr virus (EBV)-associated early antigens (EA) and the viral capsid antigen (VCA) were determined by ELISA on 263 sera obtained from healthy donors, patients with Hodgkin's disease (HD), non-Hodgkin lymphomas (NHL), infectious mononucl
## Abstract ## Background Genetic manipulation of the allograft is an attractive approach to prevent the graft against chronic deterioration through stable expression of immunomodulatory or protective genes. However, the best strategy for prevention of chronic allograft deterioration remains uncle